FLRE - Flameret Inc. - November 7 - 2011 "Flameret Inc. Announces Primary Earnings per Share of $.57 for Fiscal Year Ended June 30, 2011!" Flameret Inc. Announces Zacks Investment Research Has Initiated Coverage. FLRE given a Target Price of $2.50 per share by leading independent research provider, Zacks Investment Research! As promised, The MarketCaliber Team has some updates for NASDAQ traded, motion picture production company FLRE to share. While we rarely revisit a stock play that we have covered before, we certainly don't hesitate to take a second look at a stock we previously covered should they have the potential for more gains, and FLRE is looking primed for another round of potentially large gains!
MC Members, When we first identified FLRE back in mid-October shares were trading around $0.006, which we felt was a very attractive entry point. Just last Monday FLRE shot up to $0.014 representing nearly 120% gains. With a 52-week high of $85.00 that occurred this past July, even with an impressive 120% gain, we believe FLRE's existing potential isn't even close to being reached.
With FLRE currently trading back around $0.0097 a share, the entry point is once again extremely attractive giving investors another opportunity to take advantage of a potentially huge rally and maximize gains even more! Begin your research by studying the information in this alert. FLRE looks like it could see some even bigger gains than before.
About Flameret Inc. Description Flameret, Inc. The Company is a provider of a fire barrier product named Flamex. As of August 31, 2010, it is marketing for sale one product named (Flamex), a textile flame retardant treatment. Flamex is a flame retardant liquid that is applied to textiles. These treated textiles are used at the production stage of such products as mattresses to resist ignition from smoldering cigarettes and resist ignition from an open-flame heat source. The Company has developed various product lines for different industries that meet worldwide flammability standards. It also sells container size and consumer size liquid Fire Retardant. Corporate Website: http://www.flameret.com
UPDATES: Just last Thursday, FLRE announced that Zacks Investment Research, a leading provider of independent equity research, has initiated coverage on the Flameret Inc. Inc. The Zacks Report released just last week indicated a Target price of $4.00 a share for FLREciting several key points: (Read More) 1. A number of films currently in development and slated for release within the next two to three years including: Catwalk, The Winter Queen, Mortal Armor: The Legend of Galahad, Romeo Spy, Voodoo Museum, The White Lily, and Neuromancer. 2. Seven Arts controls copyright interests for 21 completed motion pictures and a film library of 14 films, which it anticipates increasing to as many as 50 to 75 over the next 5 years. 3. The number of films produced is waning and major studios have cut back on distributing smaller budget pictures and focused on larger budget films and franchises, creating a void for companies like FLRE to fill, especially with films like Neuromancer which could provide significant revenues beyond those typically generated from Seven Arts films in the past. In addition, on November 3rd, 2011, CEO of FLRE, Peter Hoffman, in a letter issued to stock holders, announced that stockholder equity, or book value has increased from the approximately $3,500,000 reported by PLC in December of 2010 to approximately $18,000,000 as of October 31, 2011. FLRE's per share equity is in excess of $1.30 as of November 3, 2011. (Read More) Let's not forget that BRG Investments, LLC purchased 250,000 shares of FLRE stock at a price of $1.00 per share back in October, with rights to purchase an additional 250,000 share at a price between $1.00 and $1.50 within the next 6 months, during which time shares of FLRE were trading at around $0.39 a share, representing a premium of almost 157% over market value! With the pullback of the larger studios in this sector, smaller studios are making a push in the motion picture industry with independent and lower budget pictures, and FLRE is rising to the top as it continues to churn out film after film with no shortage of press surrounding them. FLRE is listed as a competitor to the likes of Lions Gate, DreamWorks, The Walt Disney Company, Sony, and other large companies. (Read more) Again with prices of FLRE back down to around $0.0097 cents a share and FLRE continuing to push forward with film releases, news of strengthened financials, and a target share price of $4.00 per share by respected leading independent equity research analysis from Zacks, FLRE looks like it could be on the verge of a major run up and just might make this past month's 120% gains pale in comparison! Whether you took advantage of FLRE already, or you're looking at FLRE for the first time, we believe there is a very real opportunity for gains and encourage you to begin your research on FLRE right away! So keep a close watch on FLRE throughout this week and as always we'll make sure to keep you up to date with information regarding FLRE as soon as it breaks!
Sincerely, The MarketCaliberTeam
Disclaimer: (Please Read Disclaimer) Never invest in any stock featured on the MarketCaliber.com website or email alerts unless you can afford to lose your entire investment. Many of the stocks featured are highly speculative. MarketCaliber.com expects to be compensated Fifteen Thousand Dollars by a third party for a one day advertising campaign regarding Flameret Inc., Inc. (FLRE.OB). MarketCaliber.com has been previously compensated Thirty Five Thousand Dollars by a third party for an advertising campaign regarding Flameret Inc., Inc. (FLRE). The third party may have shares and may sell there shares at any time. Please understand that it is possible that this could have a negative effect on the stock price. None of the MarketCaliber.com employees are registered as investment advisors, financial analysts, brokers, or dealers in any jurisdiction whatsoever. Your use of the MarketCaliber.com website, email alerts, and all other services means that you agree to hold MarketCaliber.com, its operators, owners, and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may sustain. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation for the purchase or sale of any securities. The information provided is obtained from sources deemed reliable, but MarketCaliber.com does not guarantee in any way the timeliness, sequence, accuracy, adequacy, or completeness of such information made regarding stocks discussed on MarketCaliber.com or in email alerts. The owner, publisher, editor and their associates are not responsible for errors and omissions. You understand and agree that at the time of any transaction you make, MarketCaliber.com employees, MarketCaliber.com affiliates, and friends and family of MarketCaliber.com owners and operators may have a position in such securities. The position may have been acquired prior to the publication of any website information or email alert. You should also be aware that the aforementioned parties do have the right to sell their positions at any time without further notification. Any opinions expressed are subject to change without notice MarketCaliber.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or persons affiliated with or associated with such companies; or is available from public sources. Read our full disclaimer at:
Market Data 
Markets 
AI
